| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/22/1992 | EP0495187A1 Protein nanomatrixes and method of production |
| 07/22/1992 | EP0495132A1 Device for energy-information exchange between objects |
| 07/22/1992 | EP0495105A1 Inhibitor of absorption of digestion product of food and drink |
| 07/22/1992 | EP0495011A1 Hydrophilic polyurethane elastomers |
| 07/22/1992 | EP0494974A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 07/22/1992 | EP0494910A1 Eye-drops. |
| 07/22/1992 | EP0493441A4 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| 07/22/1992 | EP0477289A4 Anhydrous oil-based liquid suspension for delivering a medicament |
| 07/22/1992 | CN1062843A Preparation for intravenous drip injection containing korean ginseng |
| 07/21/1992 | US5132324 Use of 3-guanidinopropionic acid in the treatment of non-insulin dependent diabetes mellitus (niddm) |
| 07/21/1992 | US5132295 Alginate of constant viscosity range for all drug batches |
| 07/21/1992 | US5132290 Antitumor agents |
| 07/21/1992 | US5132117 Polymeric Lewis Acids, Lewis Bases |
| 07/21/1992 | US5132116 Constant, long-term release of active agent; sieving and mixing swelling agent, diluent and active agent; adding lubricant and mixing; compressing in rotary production machine |
| 07/21/1992 | US5132115 Transdermal drug administration |
| 07/21/1992 | US5132114 Compositions and methods of manufacture of compressed powder medicaments |
| 07/21/1992 | CA1305492C Tertio-butylic derivatives of benzylidenecamphor, process for their preparation, their use as anti-oxidants, and cosmetic and pharmaceutic compositions containing them |
| 07/21/1992 | CA1305426C Medicated skin preparation |
| 07/21/1992 | CA1305423C Pharmaceutical preparations for topical application, processes for theirmanufacture, and their use |
| 07/21/1992 | CA1305418C Transdermal delivery of pharmaceuticals |
| 07/21/1992 | CA1305417C Stable formulations of ricin toxin a chain and of rta-immunoconjugates and stabilizer screening methods therefor |
| 07/21/1992 | CA1305414C Process for preparing an improved composition of the zinc salt of bacitracin for veterinary use as growth promoter |
| 07/21/1992 | CA1305384C User-activated transdermal therapeutic system |
| 07/20/1992 | CA2059602A1 Pour-on formulation for the administration of anthelmintics |
| 07/15/1992 | WO1992011841A1 Anti-hiv activity of liposomal nystatin and amphotericin b |
| 07/15/1992 | EP0494777A1 (S)-11-Hydroxy-10-methyl aporphine and pharmaceutical compositions containing it |
| 07/15/1992 | EP0494654A2 Stable pharmaceutical composition and method for its production |
| 07/15/1992 | EP0494615A1 Echo contrast agent |
| 07/15/1992 | EP0494418A1 Process for preparing concentrated choline chloride on a natural carrier in a batch process |
| 07/15/1992 | EP0494417A2 Process for crosslinking gelatin and for incorporation a material therein |
| 07/15/1992 | EP0494412A2 Stable emulsions of perfluoropolyethers and fat substances and process for preparing them |
| 07/15/1992 | EP0358709B1 Diabetic control by combined insulin forms |
| 07/15/1992 | EP0357773B1 Process for preparing liposomes |
| 07/15/1992 | EP0346472B1 Process for preparing liposomes |
| 07/15/1992 | EP0223831B1 Liposome inhalation method and system |
| 07/15/1992 | CN1062660A Made method of cigarette with traditional chinese medicine curative effect |
| 07/15/1992 | CN1062656A Making technology of canceration shutoff agent zengshengping |
| 07/15/1992 | CN1062654A Gel type compositions having improved oil control |
| 07/15/1992 | CA2099772A1 Anti-hiv activity of liposomal nystatin and amphotericin b |
| 07/14/1992 | USRE33994 Pharmaceutical delivery system |
| 07/14/1992 | US5130479 Hydrolytically degradable hydrophilic gels and the method for preparation thereof using n,o-dimethacryloylhydroxylamine as a cross-linking agent |
| 07/14/1992 | US5130412 Electrochemical drug release and article |
| 07/14/1992 | US5130305 Cyclophosphamide - sodium bicarbonate lyophilizates |
| 07/14/1992 | US5130300 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130299 Method for enhancing growth of mammary parenchyma |
| 07/14/1992 | US5130298 Stabilized compositions containing epidermal growth factor |
| 07/14/1992 | US5130230 Blood substitute |
| 07/14/1992 | US5130171 Polysilane, polysiloxane copolymer for spraying and drying |
| 07/14/1992 | US5130140 Dry compression to form tablets from free-flowing particles by dry mixing with high shear, drying and milling |
| 07/14/1992 | US5130122 Oral cavity and dental microemulsion products |
| 07/14/1992 | US5129877 Receptor-mediated delivery system |
| 07/14/1992 | CA1305059C Stabilized menadione bisulfite formulations and their preparation |
| 07/14/1992 | CA1305058C Parenteral suspension containing diclofenac |
| 07/14/1992 | CA1305054C2 Encapsulation of antineoplastic agents in liposomes |
| 07/14/1992 | CA1304996C Process to facilitate the formation of diosoms dispersed in an aqueous phase and to improve their stability and their encapsulation rate and corresponding aspersions |
| 07/14/1992 | CA1304894C Vesicle ink compositions |
| 07/12/1992 | CA2059142A1 11-hydroxyaporphines and their biologically active salt forms as 5-ht1a inhibitors |
| 07/09/1992 | WO1992011839A1 Anhydrous aerosol |
| 07/09/1992 | WO1992011083A1 Apparatus and method for making microcapsules |
| 07/09/1992 | WO1992011003A1 Pharmaceutical compositions |
| 07/09/1992 | WO1992011002A1 Wet powder film-forming compositions |
| 07/09/1992 | WO1992011001A1 Oral pharmaceutical composition |
| 07/09/1992 | WO1992010998A1 Aqueous vaginal douche and related methods |
| 07/09/1992 | WO1992010996A1 Enhanced bioavailability pharmaceutical composition containing probucol |
| 07/09/1992 | WO1992010989A1 Cosmetic or pharmaceutical composition in the form of a rigid gel, particularly for containing inclusions therein |
| 07/09/1992 | WO1992006599A3 Vaccine compositions for fish |
| 07/09/1992 | CA2099984A1 Anhydrous aerosol |
| 07/08/1992 | WO1992011860A1 Topical formulation of cyclosporine |
| 07/08/1992 | EP0494057A1 Hydrolytic stabilizer for water soluble bis-quaternary pyridinium oximes |
| 07/08/1992 | EP0493578A1 Method of preparing mixtures of active ingredients and excipients using liquid carbon dioxide |
| 07/08/1992 | EP0493496A1 Ibuprofen triturates and topical compositions containing same |
| 07/08/1992 | EP0493489A1 Film-enrobed unitary-core medicament and the like. |
| 07/08/1992 | EP0493485A1 Erection-inducing methods and compositions |
| 07/08/1992 | EP0493441A1 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants. |
| 07/08/1992 | EP0493404A1 Topical antiinflammatory compositions with minimal systemic absorption |
| 07/08/1992 | EP0493380A1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs. |
| 07/08/1992 | EP0485486A4 Process for disinfecting musculoskeletal tissue and tissues prepared thereby |
| 07/08/1992 | EP0478702A4 Encapsulation process |
| 07/08/1992 | EP0309519B1 Pharmaceutical compositions containing pentamidine |
| 07/08/1992 | EP0239605B1 Structures for controlled chemical release |
| 07/08/1992 | CN1062466A Process for preparing navel-warming plaster |
| 07/08/1992 | CA2077647A1 Topical formulation of cyclosporine |
| 07/07/1992 | US5128376 Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator |
| 07/07/1992 | US5128373 Storage stability |
| 07/07/1992 | US5128326 Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| 07/07/1992 | US5128324 Transdermally applicable pharmaceutical preparations with sterolines and/or spiroketalines |
| 07/07/1992 | US5128318 High density lipoprotein, anticholesterol |
| 07/07/1992 | US5128249 Stable sulpho-adenosyl-l-methionine (same) salts, particularly suitable for oral pharmaceutical use |
| 07/07/1992 | US5128204 Magnetizable microspheres based on a polysilsesquioxane and a process for their preparation |
| 07/07/1992 | US5128151 Stabilized menadione bisulfite formulations and their preparation |
| 07/07/1992 | US5128147 Heat intensifier and localizer for radiofrequency thermotherapy |
| 07/07/1992 | US5128145 Dosage form for Parkinson's disease, spasticity and muscle spasms |
| 07/07/1992 | US5128144 Pressing having sustained release of active compound |
| 07/07/1992 | US5128143 Xnathan gum, galactomannan gum |
| 07/07/1992 | US5128142 Sustained release drug delivery system |
| 07/07/1992 | US5128141 Otorhinolaryngological disorders |
| 07/07/1992 | US5128140 Gastrointestinal disorders; salt of bismuth, organic acid and an H2 receptor blocking anti-secretory agent |
| 07/07/1992 | US5128139 Composition containing liposome-entrapped grapefruit seed extract and method for making |
| 07/07/1992 | US5128138 Estradiol compositions and methods for topical application |
| 07/07/1992 | US5128137 Parallel reservoir members bonded by mask; impermeable backing and protective layer |